These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
205 related articles for article (PubMed ID: 17436683)
1. [Potentiation of NO-dependent activation of soluble guanylate cyclase by polyamines]. Severina IS; Piatakova NV; Shchegolev AIu Biomed Khim; 2007; 53(1):44-9. PubMed ID: 17436683 [TBL] [Abstract][Full Text] [Related]
2. [Potentiation of nitric oxide-dependent activation of soluble guanylate cyclase by levomycetin, tetracycline, and oxolin]. Shchegolev AIu; Sidorova TA; Severina IS Biomed Khim; 2009; 55(3):331-7. PubMed ID: 19663005 [TBL] [Abstract][Full Text] [Related]
3. [YC-1-like potentiation of nitric oxide-dependent activation of soluble guanylyl cyclase by adrenochrome]. Severina IS; Piatakova NV; Shchegolev AIu; Sidorova TA Biomed Khim; 2008; 54(6):679-86. PubMed ID: 19205427 [TBL] [Abstract][Full Text] [Related]
4. [Potentiation of activation of soluble guanylate cyclase by YC-1, NO-donors and increase of the synergistic effect of YC-1 on NO-dependent activation of the enzyme by 1,2,3-triazolyl-1,2,5-oxadiazole derivatives]. Severina IS; Pyatakova NV; Shchegolev AY; Rozhkov VY; Batog LV; Makhova NN Biomed Khim; 2015; 61(6):705-11. PubMed ID: 26716741 [TBL] [Abstract][Full Text] [Related]
5. [Nitric oxide. Potentiation of NO-dependent activation of soluble guanylate cyclase--(patho)physiological and pharmacotherapeutical significance]. Severina IS Biomed Khim; 2007; 53(4):385-99. PubMed ID: 18035720 [TBL] [Abstract][Full Text] [Related]
6. [Potentiation of NO-dependent activation of soluble guanylyl cyclase by 5-nitroisatin and antiviral preparatation arbidol]. Severina IS; Shchegolev AIu; Medvedev AE Biomed Khim; 2013; 59(3):295-304. PubMed ID: 23987067 [TBL] [Abstract][Full Text] [Related]
7. YC-1-like potentiation of NO-dependent activation of soluble guanylate cyclase by derivatives of protoporphyrin IX. Severina IS; Pyatakova NV; Shchegolev AY; Ponomarev GV Biochemistry (Mosc); 2006 Mar; 71(3):340-4. PubMed ID: 16545073 [TBL] [Abstract][Full Text] [Related]
8. [Soluble guanylate cyclase in the molecular mechanism underlying the therapeutic action of drugs]. Piatakova NV; Severina IS Biomed Khim; 2012; 58(1):32-42. PubMed ID: 22642150 [TBL] [Abstract][Full Text] [Related]
9. [Soluble forms of guanylate cyclases: mechanism of activation by nitrogen oxide and role in platelet aggregation]. Severina IS Vestn Ross Akad Med Nauk; 1995; (2):41-6. PubMed ID: 7756930 [TBL] [Abstract][Full Text] [Related]
10. Ambroxol as an inhibitor of nitric oxide-dependent activation of soluble guanylate cyclase. Severina IS; Bussygina OG; Pyatakova NV; Khropov YV; Krasnoperov RA Eur J Pharmacol; 2000 Oct; 407(1-2):61-4. PubMed ID: 11050291 [TBL] [Abstract][Full Text] [Related]
11. Soluble guanylyl cyclase activator YC-1 inhibits human neutrophil functions through a cGMP-independent but cAMP-dependent pathway. Hwang TL; Hung HW; Kao SH; Teng CM; Wu CC; Cheng SJ Mol Pharmacol; 2003 Dec; 64(6):1419-27. PubMed ID: 14645672 [TBL] [Abstract][Full Text] [Related]
12. Expression and activity of soluble guanylate cyclase in injury and repair of anti-thy1 glomerulonephritis. Peters H; Wang Y; Loof T; Martini S; Kron S; Krämer S; Neumayer HH Kidney Int; 2004 Dec; 66(6):2224-36. PubMed ID: 15569311 [TBL] [Abstract][Full Text] [Related]
13. Stimulation of soluble guanylate cyclase slows progression in anti-thy1-induced chronic glomerulosclerosis. Wang Y; Krämer S; Loof T; Martini S; Kron S; Kawachi H; Shimizu F; Neumayer HH; Peters H Kidney Int; 2005 Jul; 68(1):47-61. PubMed ID: 15954895 [TBL] [Abstract][Full Text] [Related]
14. Regulation of soluble guanylyl cyclase activity by oestradiol and progesterone in the hypothalamus but not hippocampus of female rats. Reyna-Neyra A; Sarkar G; Etgen AM J Neuroendocrinol; 2007 Jun; 19(6):418-25. PubMed ID: 17388815 [TBL] [Abstract][Full Text] [Related]
15. Antitumor antibiotic streptonigrin and its derivatives as inhibitors of nitric oxide-dependent activation of soluble guanylyl cyclase. Severina IS; Pyatakova NV; Postnikov AB; Preobrazhenskaya MN; Khropov YV Eur J Pharmacol; 2004 Jan; 483(2-3):127-32. PubMed ID: 14729099 [TBL] [Abstract][Full Text] [Related]
16. Synthesis and evaluation of a phosphonate analogue of the soluble guanylate cyclase activator YC-1. Martin NI; Derbyshire ER; Marletta MA Bioorg Med Chem Lett; 2007 Sep; 17(17):4938-41. PubMed ID: 17587571 [TBL] [Abstract][Full Text] [Related]
17. YC-1 potentiates the antiplatelet effect of hydrogen peroxide via sensitization of soluble guanylate cyclase. Wu CC; Kuo SC; Lee FY; Teng CM Eur J Pharmacol; 1999 Sep; 381(2-3):185-91. PubMed ID: 10554886 [TBL] [Abstract][Full Text] [Related]
18. Benzodifuroxan as an NO-dependent activator of soluble guanylate cyclase and a novel highly effective inhibitor of platelet aggregation. Bussygina OG; Pyatakova NV; Khropov YV; Ovchinnikov IV; Makhova NN; Severina IS Biochemistry (Mosc); 2000 Apr; 65(4):457-62. PubMed ID: 10810184 [TBL] [Abstract][Full Text] [Related]
19. Effect of isatin on nitric oxide-stimulated soluble guanylate cyclase from human platelets. Medvedev A; Bussygyna O; Pyatakova N; Glover V; Severina I Biochem Pharmacol; 2002 Feb; 63(4):763-6. PubMed ID: 11992646 [TBL] [Abstract][Full Text] [Related]
20. Stimulation of guanylate cyclase by sodium nitroprusside, nitroglycerin and nitric oxide in various tissue preparations and comparison to the effects of sodium azide and hydroxylamine. Katsuki S; Arnold W; Mittal C; Murad F J Cyclic Nucleotide Res; 1977 Feb; 3(1):23-35. PubMed ID: 14978 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]